State support and the decisions taken by the government made it possible to correctly invest credit money so that the enterprise could operate and meet its obligations,” said Yuri Shuleiko.

After entering 2026 hungry for deals, Gilead Sciences has wasted no time eating its fill. | After entering 2026 hungry for ...

Shares of biotech Replimune Group sank more than 19% after the Food and Drug Administration rejected an application seeking ...

SARAH-JAYNE Crawford had high hopes for the weight loss jab Wegovy to slim her 19st figure for her wedding day. She’d read ...

Artificial intelligence has long been seen as a way to supercharge drug development. | Artificial intelligence has long been seen as a way to supercharge drug development. But a whole new frontier of ...

By David Adenuga, Bauchi The Pink Fleur Foundation has urged government at all levels to prioritise the growth of the creative industry and protect green spaces, describing both as key to innovation, ...

Gilead Sciences has inked three deals this year so far totaling $14.77 billion, a marked escalation of the company’s usual ...

Nigeria is losing an estimated $8–$9 billion annually to foreign shipping lines due to its absence in international maritime ...

CEO Dr Eric Leire talked with Proactive's Stephen Gunnion about encouraging results from the SLAB (Sarcopenia and Longevity ...

Cell and gene therapies are moving towards correcting root causes of diseases. Let's take a look at future cell and gene therapy trends.

As biotechs face increasingly tight development timelines, scale-up headaches and, more recently, unpredictable policy fluctuations, one way to stand out as a CDMO partner is picking a specialty an | ...

Art and photography by Pink Fleur Foundation has appealed to the government to create an enabling environment for creatives ...